Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Stock Performance
The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The stock has a 50 day moving average of C$2.00 and a 200 day moving average of C$2.00. The stock has a market capitalization of C$21.54 million and a P/E ratio of -12.66.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
See Also
- Five stocks we like better than Liberty Biopharma
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What Are Growth Stocks and Investing in Them
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- ESG Stocks, What Investors Should Know
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
